| EPB229 | No pharmacokinetic interaction between islatravir and methadone | E-poster | Clinical issues in people who use drugs |
| EPF101 | No rights, no health: Women Sex Workers in Latin America and the Caribbean build evidence on cases of violence and violation of our rights | E-poster | Legal advocacy tools and strategies |
| EPB106 | Non-alcoholic to metabolic associated fatty liver disease: cardiovascular implications of a change in terminology in patients living with HIV | E-poster | Other non-communicable diseases |
| EPA002 | Non-canonical role of Hsp90 isoforms in HIV-1 infection | E-poster | HIV biology (entry, replicative cycle, transcriptional expression and regulation) |
| EPB122 | Non-invasive identification of severe NAFLD and risk stratification of clinical outcomes using Fibroscan-AST (FAST) score in 1683 people with HIV | E-poster | Hepatic complications (e.g., NASH) |
| EPE012 | Not just about knowledge and money: most Taiwanese sexual health physicians require standard operating procedure and non-physician professionals' support to deliver PrEP services | E-poster | Implementation science of scaling up prevention (including PrEP) |
| PESAA02 | Novel roles for PSGL-1 in HIV infection: virions with incorporated PSGL-1 can be captured by selectins and transferred to permissive cells | Poster exhibition | HIV biology (entry, replicative cycle, transcriptional expression and regulation) |
| EPLBC07 | Number of pregnancies and its impact on adherence to ART during pregnancy in women living with HIV, followed up in 2020 in a specialized health center in São Paulo, Brazil | E-poster | Strategies to improve re-engagement |
| EPE066 | Observed time to HIV treatment initiation in the era of same-day initiation in Malawi, South Africa, and Zambia | E-poster | Implementation science of scaling up HIV treatment |
| EPC315 | Obstacles to using event-driven (2-1-1) PrEP: exploring the role of reported barriers on PrEP dosing choice in a national US sample | E-poster | Other new HIV prevention tools |